Home Rheumatology Slipped upper femoral epiphysis

Slipped upper femoral epiphysis

Slipped Upper Femoral Epiphysis (SUFE/SCFE)

Slipped Upper Femoral Epiphysis (SUFE), also known as Slipped Capital Femoral Epiphysis (SCFE), is an acute or chronic displacement of the proximal femoral epiphysis through the growth plate. The femoral head slips in a posteromedial direction relative to the femoral neck.

SUFE is a surgical emergency requiring urgent orthopedic intervention. Delay in diagnosis and treatment significantly increases morbidity, including avascular necrosis and chondrolysis. Incidence is approximately 2 per 100,000 children, with bilateral involvement in 20-40% of cases.

Pathophysiology

SUFE results from instability of the growth plate due to:

  • Endocrine risk factors: Hypothyroidism, growth hormone deficiency, hypogonadism, diabetes mellitus, panhypopituitarism
  • Metabolic bone disease: Renal osteodystrophy, hypophosphatemic rickets
  • Obesity: Major risk factor; associated with metabolic and mechanical factors leading to physeal weakness
  • Rapid growth: Adolescent growth spurt creates mechanical stress on growth plate
  • Genetic factors: Familial clustering reported; increased risk in first-degree relatives
  • Mechanical factors: Hip varus, retroversion, increased femoral anteversion

Two clinical presentations:

  • Acute SUFE: Sudden onset with acute trauma; severe pain; inability to weight-bear
  • Chronic SUFE: Insidious onset over weeks to months; mild symptoms; positive Drehmann sign

Acute slips on chronic slips (acute-on-chronic) represent acute decompensation of previously asymptomatic chronic slip โ€” particularly high-risk for complications.

Clinical Presentation

Classic presenting complaint: Groin, hip, thigh, or knee pain (often referred to knee) with limp in adolescent, frequently obese.

Physical examination findings:

  • Gait: Antalgic limp or inability to bear weight
  • Hip position: Hip held in flexion and external rotation
  • Range of motion: Severe loss of internal rotation; hip flexion contracture
  • Drehmann sign: POSITIVE โ€” when hip is flexed passively, it obligatorily externally rotates (pathognomonic sign)
  • Trendelenburg sign: Positive; indicates hip muscle weakness
  • No systemic symptoms: Absence of fever distinguishes from infection

Important: SUFE must be distinguished from:

  • Septic arthritis (fever, elevated inflammatory markers, toxic appearance)
  • Femoral shaft fracture (history of significant trauma, very acute onset)
  • Developmental dysplasia (diagnosed in infancy, different age group)

Investigations

Plain Radiography (First-line, required before any other intervention):

  • Anteroposterior (AP) view of pelvis: shows posteromedial femoral head displacement relative to femoral neck
  • Frog-lateral view (internal rotation): mandatory โ€” sensitivity much higher than AP alone. Shows slip clearly
  • Klein's line: On AP view, draw line along superior femoral neck margin. Normal femoral head intersects this line; in SUFE, femoral head lies below the line (pathognomonic)
  • Bilateral films essential โ€” 20-40% bilateral involvement; contralateral hip may show early asymptomatic slip

Magnetic Resonance Imaging (MRI):

  • Excellent for detecting pre-slip changes in contralateral hip
  • Shows marrow edema and physeal widening before radiographic changes
  • Not required for diagnosis but useful for prophylactic evaluation

Laboratory tests: Check for endocrine abnormalities:

  • Thyroid function tests (TSH, free T4)
  • Growth hormone assessment if indicated by growth history
  • Fasting glucose, metabolic markers
  • ESR/CRP โ€” normal; elevated suggests infection rather than SUFE

Severity Classification

Stable SUFE (Loder Classification)
Child able to weight-bear on affected hip. Pain present but manageable. Lower risk of complications. Still requires urgent surgical fixation but can be performed within 24-48 hours
Unstable SUFE
Child unable to weight-bear even with crutches due to severe pain. High risk of avascular necrosis. Requires emergent surgical intervention within 6-12 hours. Associated with significant morbidity
Acute-on-Chronic SUFE with Complications
Acute decompensation of chronic asymptomatic slip. Very high risk of AVN and chondrolysis. Requires emergency intervention and intensive monitoring

Severity also classified by degree of slip:

  • Mild: <50% epiphyseal width displaced
  • Moderate: 50-99% displacement
  • Severe: >100% displacement (femoral head slips beyond opposite femoral neck margin)

Treatment Principles

SURGICAL EMERGENCY: Do NOT weight-bear. Do NOT massage or manipulate hip. Do NOT delay surgical fixation. In-situ pinning is gold standard treatment

Immediate management:

  • Non-weight-bearing status: Immediate cessation of weight-bearing to prevent acute-on-chronic conversion and reduce AVN risk
  • Orthopedic referral: Emergent referral to orthopedic surgery. Do NOT send child home or to ED observation
  • Imaging: AP and frog-lateral radiographs mandatory before surgery; bilateral films to assess contralateral hip
  • Avoid manipulation: Forceful reduction increases AVN risk

Surgical treatment:

  • Stable SUFE: Percutaneous in-situ pinning with single cannulated screw. Gold standard. Performed within 24-48 hours
  • Unstable SUFE: Emergency in-situ pinning. Perform within 6-12 hours when possible. Extensive preoperative AVN risk
  • Severe slip with complications: May require open reduction and internal fixation or subtrochanteric derotation osteotomy if significant deformity develops

Contralateral hip prophylaxis (Controversial):

  • 15-25% risk of SUFE in asymptomatic contralateral hip
  • Prophylactic pinning vs. observation: varies by surgeon and institution
  • MRI can identify pre-slip changes to guide prophylaxis decision
  • Close radiographic monitoring (X-rays every 4-6 weeks) if observation chosen

Pharmacological Management

Note: SUFE is a surgical condition. Medical therapy is perioperative analgesia only.

💊
Paracetamol
Paracetamol โ€” perioperative analgesia
DOSE10-15 mg/kg/dose oral/IV, 4-6 hourly (max 5 doses daily)
PBS STATUS✓ PBS: General benefit
NOTESFirst-line analgesic for perioperative pain management post-surgical fixation
💊
NSAIDs
NSAIDs โ€” perioperative pain control
DOSEIbuprofen 5-10 mg/kg/dose oral 6-8 hourly OR ketorolac 0.5 mg/kg IV (max 30 mg) post-op
PBS STATUS✓ PBS: General benefit
NOTESUse cautiously post-operatively; may reduce inflammation. AVOID pre-operatively due to bleeding risk. Use only 48-72 hours if at all

Acute Management

RED FLAG โ€” SURGICAL EMERGENCY: Any adolescent with hip/groin/knee pain and inability to weight-bear until proven otherwise is SUFE until proven otherwise. Urgent orthopedic referral required. Do NOT delay for further imaging or specialist consultation

Diagnostic algorithm:

  • Take weight-bearing history: can child ambulate? Can child weight-bear on affected side?
  • Check for Drehmann sign (obligate external rotation with hip flexion) โ€” highly specific for SUFE
  • Obtain STAT AP and frog-lateral pelvis radiographs (bilateral) if SUFE suspected
  • Review Klein's line on AP view โ€” is femoral head below the line?
  • Contact orthopedic surgery immediately if diagnosis confirmed or highly suspected

Do NOT:

  • Allow weight-bearing (increases slip and AVN risk)
  • Perform hip manipulations or aggressive range of motion testing
  • Delay surgical referral for additional imaging
  • Discharge home pending orthopedic appointment
  • Assume this is "growing pain" or soft tissue injury

Endocrine screening: Check thyroid function (TSH), growth hormone status, fasting glucose, metabolic markers. Many SUFE patients have underlying endocrine abnormalities requiring treatment.

Monitoring and Follow-up

Immediate (within hours)
Radiographic confirmation, orthopedic referral, non-weight-bearing status, IV analgesia if severe pain
0-24 hours
Urgent surgical fixation for unstable slip; preparation for stable SUFE surgery within 24-48 hours
Post-operative day 1
Early mobilization, pain control, assess for compartment syndrome or vascular compromise, DVT prophylaxis if appropriate
2-4 weeks
Begin weight-bearing progression as tolerated; physical therapy for hip range of motion and strength; assess screw position on radiographs
6-12 weeks
Continue rehabilitation; assess for AVN symptoms (pain with movement); bilateral hip imaging if contralateral prophylaxis not performed
3-6 months and beyond
Monitor for late complications: AVN, chondrolysis, secondary OA. Endocrine follow-up for underlying conditions

Post-operative monitoring:

  • Pain trajectory: Pain should improve post-operatively; persistent or increasing pain suggests AVN or infection
  • Limb perfusion: Monitor for calf swelling, cyanosis, coolness suggesting DVT or vascular compromise
  • Radiographs: Assess screw position, degree of slip correction. Additional imaging (CT, MRI) if AVN suspected
  • Hip range of motion: Gradual improvement in internal rotation and abduction; contractures should resolve
  • Contralateral hip assessment: Radiographs every 4-6 weeks if observation chosen; immediate imaging if symptoms develop

Special Populations

Obese adolescents: Markedly increased risk of SUFE. Metabolic syndrome, insulin resistance, and endocrine abnormalities common. Requires aggressive weight management post-operatively and endocrine assessment.

Endocrine disorders: Hypothyroidism, growth hormone deficiency, hypogonadism, diabetes all increase SUFE risk. Requires endocrine specialist input for hormone replacement or thyroid management.

Renal disease: Secondary hyperparathyroidism and renal osteodystrophy increase SUFE risk. Requires close collaboration with nephrology for mineral metabolism management.

Bilateral SUFE (20-40% of cases): Usually sequential presentation; contralateral hip may be asymptomatic but at risk. Prophylactic pinning vs. serial monitoring decision made by orthopedic surgeon. Excellent outcome if bilateral slips treated appropriately.

ATSI Health Considerations

Obesity Epidemic
ATSI communities have higher rates of obesity in adolescents, increasing SUFE risk. Implement community-level weight management and metabolic health programs. Early identification of at-risk youth
Access to Urgent Orthopedic Surgery
Limited availability of emergency orthopedic services in remote areas. Establish clear referral pathways to major surgical centers. Facilitate rapid transport for eligible patients with confirmed or suspected SUFE
Endocrine Screening and Management
ATSI youth may have undiagnosed endocrine disorders (hypothyroidism, GH deficiency). Ensure screening in all SUFE patients and appropriate specialist follow-up for comorbid conditions
Long-term Rehabilitation Support
Post-operative recovery requires sustained physiotherapy and activity modification. Provide community health worker support, culturally appropriate rehabilitation programs, and sport/recreation guidance

Clinical Stewardship

Diagnostic stewardship: Plain radiography (AP and frog-lateral) is diagnostic and sufficient. MRI reserved for contralateral hip assessment or complications. CT not needed for uncomplicated SUFE. Avoid delays in diagnosis for advanced imaging.

Surgical stewardship: In-situ pinning is gold standard; simple, effective, single-stage procedure. Reserve open reduction and osteotomy for severe slips or failed in-situ fixation. Avoid aggressive reduction techniques that increase AVN risk.

Medication stewardship: Paracetamol is first-line perioperative analgesia. NSAIDs used cautiously and briefly post-operatively only. Avoid prolonged use post-operatively; healing prioritized over analgesia.

Endocrine stewardship: Screen all SUFE patients for underlying endocrine abnormalities. Refer to endocrinology for identified disorders. Address metabolic risk factors (obesity, insulin resistance) to reduce contralateral SUFE risk.

Follow-up and Long-term Outcomes

Immediate post-operative outcomes: Most children recover well after in-situ pinning. Pain resolves over 2-4 weeks. Weight-bearing progresses to full capacity by 8-12 weeks.

Major complications and their incidence:

  • Avascular Necrosis (AVN): 0-5% in stable slips; up to 20-40% in unstable slips. Risk highest with unstable presentation or delayed fixation. AVN may be clinically silent initially
  • Chondrolysis: Arthritis and joint space narrowing; can occur post-operatively even with appropriate surgery. Incidence 5-10%
  • Contralateral SUFE: 20-40% bilateral involvement; may occur weeks to years later
  • Early osteoarthritis: Can develop in adolescence/early adulthood, particularly with residual deformity or AVN

Long-term functional outcomes: With appropriate prompt surgical fixation, most adolescents return to normal activities including sports. Severe complications (AVN, chondrolysis) may limit activities and require activity modification into adulthood.

Contralateral hip surveillance: If prophylactic pinning not performed, patient requires radiographic monitoring (every 4-6 weeks for 1 year, then 6-monthly) for development of slip. Any symptoms warrant immediate radiographs.

Transition to adulthood: SUFE patients entering adulthood require transition to adult orthopedic care. Discuss long-term hip health, impact of obesity and metabolic factors, hip OA risk factors, and sport/activity limitations if any.

Prevention in future generations: Counsel on modifiable risk factors (obesity, metabolic syndrome) for their own children. Screen first-degree relatives if endocrine conditions identified.

Key References

  • American Academy of Orthopaedic Surgeons (AAOS): Guidelines on Slipped Capital Femoral Epiphysis
  • Pediatric Orthopedic Society of North America (POSNA): SCFE diagnosis and management standards
  • International Hip Dysplasia Institute: Evidence-based SCFE treatment recommendations
  • Australian Orthopaedic Association: SUFE emergency management and surgical protocols
  • eTG - Therapeutic Guidelines: Slipped upper femoral epiphysis in adolescents